Abstract
Hepatitis B virus (HBV) is the most meaningful risk factor in chronic hepatitis, cirrhosis and primary hepatocellular carcinoma (PHC). The hepatitis B virus X protein (HBxAg) is a multifunctional protein with many important functions in hepatocellular carcinogenesis. A monoclonal anti-HBxAg antibody was developed in our laboratory and characterized by different methods. Using this antibody HBxAg was detected in formaldehyde fixed paraffin embedded tissue sections of 72 liver biopsies from patients with acute hepatitis, chronic hepatitis, cirrhosis and primary hepatocellular carcinoma. The co-expression of hepatitis B surface antigen (HBsAg), hepatitis B core antigen (HBcAg) and HBxAg was compared. The histological and cytological localization of the detected HBxAg showed a characteristic distribution in different stages of HBV infection. Strong and diffuse nuclear reaction was detected in PHC cases in contrast to the focal, cytoplasmic and nuclear labeling in the acute and chronic B hepatitis cases. Our antibody seems to be a suitable prognostic marker for routine pathohistological diagnosis and for comparative pathological and epidemiological research on the development of PHC.
Similar content being viewed by others
References
Andrisani OM, Barnabas S; The transcriptional function of the hepatitits B virus X protein and its role in hepatocarcinogenesis. (Review) Internat J Oncol 15:373–379, 1999.
Balogh P, Szekeres Gy, Németh P; Hapten-mediated identification of cell membrane antigens using an anti-FITC monoclonal antibody. J Immunol Method 169:35–40, 1994.
Brechot C; Molecular Mechanisms of Hepatitis B and C Viruses Related to Liver Carcinogenesis. Hepato-Gastroenterology 45:1189–1196, 1998.
Diamantis ID, McGandy CE, Chen TJ, et al; Hepatitis B X-gene expression in hepatocellular carcinoma. J Hepatol 15:400–403, 1992.
Doria M, Klein N, Lucito R, et al; The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of Transcription factor. EMBO J 14:4747–4757, 1995.
Engwall E, Perlmann P; Enzyme-linked immunossorbent assay, ELISA. 3. Quantitation of specific antibodies by enzyme-labelled anti-immunglobulin in antigen-coated tubes. J Immunol 109:129–135, 1972.
Feitelson MA, Clayton MM; X antigen polypeptides in the sera of hepatitis B virus-infeceted patients. Virology 177:367–371, 1990.
Feitelson MA, Clayton MM, Blumberg BS; X antigen/antibody markers in hepadnavirus infections. Gastroenterology 98:1071–1078, 1990.
Feitelson MA; Hepatitis B virus infection and primary hepatocellular carcinoma. Clin Microbiol Rev 5:275–301, 1992.
Feitelson MA, Zhu M, Duan L-X andLondon WT; Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8:1109–1117, 1993.
Feitelson MA; Hepatitis B Virus in hepatocarcinogenesis J Cellular Physiol 181:188–202, 1999.
Feitelson MA, Duan L; Hepatitis B Virus x Antigen in the Pathogenesis of Chronic infections and the Development of Hepatocellular Carcinoma. (Review). Amer J Pathol 150:4, 1997.
Gupta A, Mal TK, Jayasuryan N, et al; Assignment of disulphide bonds in the X protein (HBx) of hepatitis B virus. Biochem Biophys Res Comm 212:919–924, 1995.
Haruna Y, Hayashi N, Katayama K, et al; Expression of X protein and hepatitis B virus replication in chronic hepatitis. Hepatology 13:417–421, 1991.
Haviv I, Shamay M, Doits G, et al; Hepatitis B virus pX targets TFIIB in transcription coactivation. Mol Cell Biol 18:1562–1569, 1998.
Henkler F, Hoare J, Waseem N, et al; A: Intracellular localization of the hepatitis B virus HBx protein. J General Virol 82:871–882, 2001.
Hess J, Stemler M, Will H, et al; Frequent detection of antibodies to hepatitis B x-protein in acute, chronic and resolved infections. Medical Microbiol Immunol 177:195–205, 1988.
Katayama K, Hayashi N, Sasaki Y, et al: Detection of Hepatitis B Virus X Gene protein and Antibody in Type B Chronic Liver DiseaseGastroenterology 97:990–998, 1989.
Kay A, Dinechin SD, Vitvitski-Trépo L, et al; Recognition of the N-Terminal, C-Terminal, and Interior Portions of HBx by Sera From Patients With Hepatitis B. J Med Virol 33:228–235, 1991.
Kim CM, Koike K, Saito I, et al; HBx gene of hepatitis B virus induced liver cancer in transgenic mice. Nature 351:317–320, 1991.
Köhler G, Milstein C; Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497, 1975.
Kumar V, Jayasuryan N, Reddi H, et al; A Monoclonal Antibody Against the X Protein of Hepatitis B Virus: Fine Mapping of its Epitope and Application in a Quantitative ELISA of the X Protein in Sera of Hepatitis B Patients. Hybridoma 17:2, 1998.
Laemmli UK; Cleave of structural proteins during the assembly of the bacteriophage T4. Nature 227:680–685, 1970.
Levrero M, Jean-Jean O, Balsano C, et al; Hepatitis B virus polypeptide x gene expression in human cells and anti-HBx antibodies detected in chronic HBV infection. Virology 174:299–304, 1990.
Malik AH, William M; Chronic Hepatitis B Virus Infection: Treatment Strategies for the Next Millenium Lee. Ann Intern Med 132:723–731, 2000.
Marczinovits I, Somogyi Cs, Patthy A, et al; An alternative purification protocol for producing hepatitis B virus X antigen on a preparative scale in Escherichia coli. J Biotechol 56:81–88, 1997.
Murakami S; Hepatitis B Virus X Protein:Sturcture, Function and Biology. Intervirology 42:81–99, 1999.
Nomura T, Lin X, Dorjsuren D, et al; Human Hepatitis B virus X protein is detectable in nuclei of transfected cells, and active for transactivation. Biochim Biophys Acta 1453:330–340, 1999.
Pfaff E, Salfeld J, Gmelin K, et al; Synthesis of the X-protein of hepatitis B virus in vitro and detection of anti-X antibodies in human sera. Virology 158:456–460, 1987.
Poussin K, Dienes H, Sirma H, et al; Expression of Mutated hepatitis B Virus x Genes in Human Hepatocellular Carcinomas. Int J Cancer 80:497–505 1999.
Seo J, Kim K, Murakami S, et al; Lack of Colocalization of HBxAg and Insulin like Growth Factor II in the Livers of Patients with Chronic Hepatitis B, Cirrhosis and Hepatocellular Carcinoma. JKMS 12:523–531, 1997.
Siddiqui A, Jameel S, Mapoles J; Expression of the hepatitis B virus X gene in mammalian cells. Proc Natl Acad Sci USA 84:2513–2517, 1987.
Sirma H, Weil R, Rosmorduc O, et al; Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with proteasome. Oncogene 16:2051–2063, 1998.
Stemler M, Weimer T, Tu Z-X, et al; Mapping of B-cell epitopes of the human hepatitis B virus X protein. J Virol 64:2802–2809, 1990.
Su Q, Schröder CH, Hoffmann WJ, et al; Expression of Hepatitis B Virus X Protein in HBV-infected human Livers and hepatocellular Carcinomas. Hepatology 27:1109–1120, 1998.
Takeuchi M, Fujimoto J, Niwamoto, et al; Frequent Detection of Hepatitis B Virus X-gene DNA in Hepatocellular Carcinoma and Adjacent Liver Tissue in Hepatitis B Surface Antigen-Negative Patients. Digestive Dis Sci 42:2264–2269, 1997.
Towbin H, Staehelin T, Gordon J; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure an some applications. Proc Natl Acad Sci USA 76:4350–4354, 1979.
Unger T, Shaul Y; The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element. EMBO J 9:1889–1895, 1990.
Vitvitski-Trepo L, Kay A, et al; Early and Freequent Detection of HBxAg and/or Anti-HBx in Hepatitis B Virus Infection. Hepatology 12:1278–1283, 1990.
Wang W, London WT, Lega L, et al; HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology 14:29–37, 1990.
Wang W, London WT, Feitelson, MA; Hepatitis B x Antigen in Hepatitis B Virus Carrier Patients with Liver Cancer Cancer Research 51:4971–4977, 1991.
Wang XW, Forrester K, Yeh H, et al; Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 91:2230–2234, 1994.
Zentgraf H, Herrman G, Klein R, et al; Mouse monoclonal antibody directed against hepatitis B virus X protein synthesized in Escherichia coli: detection of reactive antigen in liver cell carcinoma and chronic hepatitis. Oncology 47:143–148, 1990.
Zhu M, London WT, Duan L-X, et al; The value of hepatitis B x antigen as a prognostic marker in the development of hepatocellular carcinoma. Int J Cancer 55:571–576, 1993.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pál, J., Somogyi, C., Szmolenszky, Á. et al. Immunohistochemical assessment and prognostic value of hepatitis B virus X protein in chronic hepatitis and primary hepatocellular carcinomas usinganti-HBxAg monoclonal antibody. Pathol. Oncol. Res. 7, 178–184 (2001). https://doi.org/10.1007/BF03032346
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03032346